Australia markets closed

Orgenesis Inc. (ORGS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5089+0.0089 (+1.78%)
At close: 04:00PM EDT
0.4874 -0.02 (-4.22%)
After hours: 06:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
530
530
36,025
35,502
7,652
Cost of revenue
6,255
6,255
5,133
28,889
31,099
Gross profit
-5,725
-5,725
30,892
6,613
-23,447
Operating expenses
Research development
10,623
10,623
21,933
7,755
52,887
Selling general and administrative
35,088
35,088
15,539
14,668
18,872
Total operating expenses
49,166
49,166
38,433
21,135
72,334
Operating income or loss
-54,891
-54,891
-7,541
-14,522
-95,781
Interest expense
2,167
2,167
1,824
943
1,254
Total other income/expenses net
-7,380
-7,380
-2,593
-2,711
-54
Income before tax
-64,445
-64,445
-11,960
-17,951
-96,736
Income tax expense
473
473
209
108
-1,609
Income from continuing operations
-64,918
-64,918
-12,169
-18,059
-95,127
Net income
-55,361
-55,361
-14,889
-18,053
1,110
Net income available to common shareholders
-55,361
-55,361
-14,889
-18,053
6,270
Basic EPS
-0.91
-1.91
-0.59
-0.74
0.29
Diluted EPS
-0.91
-1.91
-0.59
-0.74
0.29
Basic average shares
27,337
29,008
25,096
24,274
21,320
Diluted average shares
27,337
29,008
25,096
24,274
21,320